De novo antibody sequencing is for research, diagnostic and therapeutic industries. It consists of variable region, variable plus leader region, and full length heavy and light chain antibody sequencing for all species. Purified monoclonal antibodies in multivalent forms can be sequenced with 100% coverage of the desired regions as well as excellent accuracy.
Board Rules | advertise | Privacy
Copyright © 2004-2012 Scientist Solutions, All Rights Reserved.Resources from NCBI used on this site.